Gornitzky & Co. represented the underwriters, led by Wells Fargo and RBC, in the USD 40 million initial public offering of SteadyMed Ltd. on the NASDAQ Global Market. SteadyMed is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parenteral delivery needs.
Wells Fargo Securities and RBC Capital Markets acted as joint book-running managers for the offering. JMP Securities acted as lead manager for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.